Emerging Role of Dual GLP 1 and GIP Receptor Agonists DMSO Dove Medical Press Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Glucose Dependent Insulinotropic Polypeptide and Glucagon Like Peptide 1 in Medicine Encyclopedia MDPI Cagrilintide vs Retatrutide for Weight Loss and Metabolic Health BetteryouRx Identification and utility exploration of a highly potent and long acting bullfrog GLP 1 analogue in GLP 1 and amylin combination therapy ScienceDirect